These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Latent and lytic Epstein-Barr virus replication strategies. Tsurumi T; Fujita M; Kudoh A Rev Med Virol; 2005; 15(1):3-15. PubMed ID: 15386591 [TBL] [Abstract][Full Text] [Related]
9. Protein kinase C-independent activation of the Epstein-Barr virus lytic cycle. Gradoville L; Kwa D; El-Guindy A; Miller G J Virol; 2002 Jun; 76(11):5612-26. PubMed ID: 11991990 [TBL] [Abstract][Full Text] [Related]
10. Genetic dissection of cell growth arrest functions mediated by the Epstein-Barr virus lytic gene product, Zta. Rodriguez A; Armstrong M; Dwyer D; Flemington E J Virol; 1999 Nov; 73(11):9029-38. PubMed ID: 10516009 [TBL] [Abstract][Full Text] [Related]
11. Cellular differentiation regulator BLIMP1 induces Epstein-Barr virus lytic reactivation in epithelial and B cells by activating transcription from both the R and Z promoters. Reusch JA; Nawandar DM; Wright KL; Kenney SC; Mertz JE J Virol; 2015 Feb; 89(3):1731-43. PubMed ID: 25410866 [TBL] [Abstract][Full Text] [Related]
12. Efficient Translation of Epstein-Barr Virus (EBV) DNA Polymerase Contributes to the Enhanced Lytic Replication Phenotype of M81 EBV. Church TM; Verma D; Thompson J; Swaminathan S J Virol; 2018 Mar; 92(6):. PubMed ID: 29263273 [TBL] [Abstract][Full Text] [Related]
13. DNA Damage Signaling Is Induced in the Absence of Epstein-Barr Virus (EBV) Lytic DNA Replication and in Response to Expression of ZEBRA. Wang'ondu R; Teal S; Park R; Heston L; Delecluse H; Miller G PLoS One; 2015; 10(5):e0126088. PubMed ID: 25950714 [TBL] [Abstract][Full Text] [Related]
14. hTERT inhibition triggers Epstein-Barr virus lytic cycle and apoptosis in immortalized and transformed B cells: a basis for new therapies. Giunco S; Dolcetti R; Keppel S; Celeghin A; Indraccolo S; Dal Col J; Mastorci K; De Rossi A Clin Cancer Res; 2013 Apr; 19(8):2036-47. PubMed ID: 23444223 [TBL] [Abstract][Full Text] [Related]
15. De novo protein synthesis is required for lytic cycle reactivation of Epstein-Barr virus, but not Kaposi's sarcoma-associated herpesvirus, in response to histone deacetylase inhibitors and protein kinase C agonists. Ye J; Gradoville L; Daigle D; Miller G J Virol; 2007 Sep; 81(17):9279-91. PubMed ID: 17596302 [TBL] [Abstract][Full Text] [Related]
16. Fatty acid synthase expression is induced by the Epstein-Barr virus immediate-early protein BRLF1 and is required for lytic viral gene expression. Li Y; Webster-Cyriaque J; Tomlinson CC; Yohe M; Kenney S J Virol; 2004 Apr; 78(8):4197-206. PubMed ID: 15047835 [TBL] [Abstract][Full Text] [Related]
17. The cellular ataxia telangiectasia-mutated kinase promotes epstein-barr virus lytic reactivation in response to multiple different types of lytic reactivation-inducing stimuli. Hagemeier SR; Barlow EA; Meng Q; Kenney SC J Virol; 2012 Dec; 86(24):13360-70. PubMed ID: 23015717 [TBL] [Abstract][Full Text] [Related]
18. Latent membrane protein 1 of Epstein-Barr virus plays an important role in the serum starvation resistance of Epstein-Barr virus-immortalized B lymphocytes. Park CH; Kim HR; Kim J; Jang SH; Lee KY; Chung GH; Jang YS J Cell Biochem; 2004 Mar; 91(4):777-85. PubMed ID: 14991769 [TBL] [Abstract][Full Text] [Related]
19. Induction of the Lytic Cycle Sensitizes Epstein-Barr Virus-Infected B Cells to NK Cell Killing That Is Counteracted by Virus-Mediated NK Cell Evasion Mechanisms in the Late Lytic Cycle. Williams LR; Quinn LL; Rowe M; Zuo J J Virol; 2016 Jan; 90(2):947-58. PubMed ID: 26537677 [TBL] [Abstract][Full Text] [Related]
20. Cell cycle arrest and lytic induction of EBV-transformed B lymphoblastoid cells by a histone deacetylase inhibitor, Trichostatin A. Seo JS; Cho NY; Kim HR; Tsurumi T; Jang YS; Lee WK; Lee SK Oncol Rep; 2008 Jan; 19(1):93-8. PubMed ID: 18097580 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]